Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma

Cancer Biology and Therapy

Volumn 16, Issue 7, 2015, Pages 1042-1046

  Hou, Bo ^a   Ishinaga, Hajime ^a   Midorikawa, Kaoru ^a   Shah, Said Ahmad ^a   Nakamura, Satoshi ^a   Hiraku, Yusuke ^a   Oikawa, Shinji ^a   Murata, Mariko ^a   Takeuchi, Kazuhiko ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; Circulating miRNA; Head and neck squamous cell carcinoma; MiR 223; MiR 99a

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 100; MICRORNA 106B; MICRORNA 1224; MICRORNA 125B; MICRORNA 1275; MICRORNA 146B; MICRORNA 155; MICRORNA 21; MICRORNA 223; MICRORNA 2861; MICRORNA 34B; MICRORNA 4286; MICRORNA 4299; MICRORNA 572; MICRORNA 638; MICRORNA 99A; MICRORNA LET 7C; UNCLASSIFIED DRUG; MIRN21 MICRORNA, HUMAN; MIRN223 MICRORNA, HUMAN; MIRN99 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN MICROARRAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BLOOD; CARCINOMA, SQUAMOUS CELL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK NEOPLASMS; MIDDLE AGED; PROCEDURES; PROGNOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSTOPERATIVE PERIOD; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84938334592     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1045692     Document Type: Article

References (22)

1. Polanska H, Raudenska M, Gumulec J, Sztalmachova M, Adam V, Kizek R, Masarik M. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol 2014; 50: 168-77; PMID: 24382422; http://dx. doi. org/10. 1016/j. oraloncology. 2013. 12. 008.
2. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-55; PMID: 19239886; http://dx. doi. org/10. 1016/j. cell. 2009. 01. 035.
3. Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev 2013; 23: 3-11; PMID: 23465882; http://dx. doi. org/10. 1016/j. gde. 2013. 01. 004.
4. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010; 101: 2087-92; PMID: 20624164; http://dx. doi. org/10. 1111/j. 1349-7006. 2010. 01650. x.
5. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8: 467-77; PMID: 21647195; http://dx. doi. org/10. 1038/nrclinonc. 2011. 76.
6. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105: 10513-8; PMID: 18663219; http://dx. doi. org/10. 1073/pnas. 0804549105.
7. Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 2012; 32: 326-48; PMID: 22383180; http://dx. doi. org/10. 1002/med. 20215.
8. Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, Li X, Tang H. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 2009; 19: 828-37; PMID: 19546886; http://dx. doi. org/10. 1038/cr. 2009. 72.
9. Reis S, Pontes-Junior J, Antunes A, Dall'Oglio M, Dip N, Passerotti C, Rossini G, Morais D, Nesrallah A, Piantino C, et al. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol 2012; 12: 14; PMID: 22642976; http://dx. doi. org/10. 1186/1471-2490-12-14.
10. Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF, Yang MY. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 2012; 33: 1933-42; PMID: 22811001; http://dx. doi. org/10. 1007/s13277-012-0454-8.
11. Maclellan SA, Lawson J, Baik J, Guillaud M, Poh CF, Garnis C. Differential expression of miRNAs in the serum of patients with high-risk oral lesions. Cancer Med 2012; 1: 268-74; PMID: 23342275; http://dx. doi. org/10. 1002/cam4. 17.
12. Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L, Heimann P, Martiat P, Bron D, Lagneaux L. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009; 113: 5237-45; PMID: 19144983; http://dx. doi. org/10. 1182/blood-2008-11-189407.
13. Li J, Guo Y, Liang X, Sun M, Wang G, De W, Wu W. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol 2012; 138: 763-74; PMID: 22270966; http://dx. doi. org/10. 1007/s00432-012-1154-x.
14. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16: 1129-39; PMID: 20145181; http://dx. doi. org/10. 1158/1078-0432. CCR-09-2166.
15. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 2008; 7: 35; PMID: 18442408; http://dx. doi. org/10. 1186/1476-4598-7-35.
16. Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, Wang C, Liu X, Zhou X. Down-regulation of the micro-RNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 2012; 48: 686-91; PMID: 22425712; http://dx. doi. org/10. 1016/j. oraloncology. 2012. 02. 020.
17. Sun D, Lee YS, Malhotra A, Kim HK, Matecic M, Evans C, Jensen RV, Moskaluk CA, Dutta A. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res 2011; 71: 1313-24; PMID: 21212412; http://dx. doi. org/10. 1158/0008-5472. CAN-10-1031.
18. Kuo YZ, Tai YH, Lo HI, Chen YL, Cheng HC, Fang WY, Lin SH, Yang CL, Tsai ST, Wu LW. MiR-99a exerts anti-metastasis through inhibiting myotubularinrelated protein 3 expression in oral cancer. Oral Dis 2014; 20: e65-75; PMID: 23731011; http://dx. doi. org/10. 1111/odi. 12133.
19. Doghman M, El Wakil A, Cardinaud B, Thomas E, Wang J, Zhao W, Peralta-Del Valle MH, Figueiredo BC, Zambetti GP, Lalli E. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res 2010; 70: 4666-75; PMID: 20484036; http://dx. doi. org/10. 1158/0008-5472. CAN-09-3970.
20. Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG, Olokpa E, Itamochi H, Ueno NT, Hawkins SM, et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 2010; 24: 447-63; PMID: 20081105; http://dx. doi. org/10. 1210/me. 2009-0295.
21. Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. starBase v2. 0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIPSeq data. Nucleic Acids Res 2014; 42: D92-7; PMID: 24297251; http://dx. doi. org/10. 1093/nar/gkt1248.
22. Yen YC, Shiah SG, Chu HC, Hsu YM, Hsiao JR, Chang JY, Hung WC, Liao CT, Cheng AJ, Lu YC, et al. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Mol Cancer 2014; 13: 6; PMID: 24410957; http://dx. doi. org/10. 1186/1476-4598-13-6.